Date: 2011-06-30
Type of information: Company acquisition
Acquired company: Cobra Biologics Holding AB (Sweden)
Acquiring company: Recipharm AB’s shares in Recipharm Cobra Biologics (Sweden)
Amount:
Terms: Recipharm AB and Cobra Biologics Holding AB have completed a transaction whereby Cobra Biologics Holding AB has acquired Recipharm AB’s shares in the operating companies of RecipharmCobra Biologics located in Keele, UK and Södertälje, Sweden.
Cobra Biologics Holding AB is the new company formed for the purposes of developing this business further. The shareholders in the new company will be made up of the Management Team, Zentricity Holding AB and Recipharm AB. Peter Coleman, who was previously General Manager of RecipharmCobra Biologics will become the CEO of Cobra Biologics Holding AB.
Cobra Biologics Holding AB will continue to trade as RecipharmCobra Biologics.
Details:
Related: Manufacturing
Production
